No menu items!
Friday, May 16, 2025

National Biopharma Mission (NBM)

DBT-BIRAC supported indigenously developed DNA Vaccine Candidate by Zydus Cadila, approved for Phase III clinical trials

The Nation’s first indigenously developed DNA vaccine candidate against COVID-19, ZyCoV-D, by M/s Zydus Cadila has been approved by Drugs Controller General of India (DCGI), for conduct of the Phase III clinical trials. The candidate has been supported by...
- Advertisement -spot_img

Latest News

India Strengthens Global Biotech Push at ICGEB Meet

India’s emergence as a global biotechnology hub was underscored at the 31st Board Meeting of Governors of the International...
- Advertisement -spot_img